Mind Medicine (NASDAQ:MNMD) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.60) by 6.67 percent. This is a 6.67 percent increase over losses of $(0.60) per share from the same period last year.
Raymond James Maintains Outperform on Oshkosh, Raises Price Target to $110
Raymond James analyst Felix Boeschen maintains Oshkosh (NYSE:OSK) with a Outperform and raises the price target from $105 to $110.
